Literature DB >> 31543437

Hepatitis A virus-associated fulminant hepatitis with human immunodeficiency virus coinfection.

Yohei Maki1, Yoshifumi Kimizuka2, Hisashi Sasaki1, Takayuki Yamamoto1, Yusuke Hamakawa1, Yoichi Tagami1, Jun Miyata1, Nobuyoshi Hayashi1, Yuji Fujikura1, Akihiko Kawana1.   

Abstract

Hepatitis A virus (HAV) commonly causes acute hepatitis in humans and is transmitted through the fecal-oral route or by ingestion of contaminated food or water. HAV infection generally follows a self-limiting course; it can seldom cause fulminant hepatitis that increases the risk of mortality. To the best of our knowledge, this is the first reported fatal case of fulminant hepatitis caused by HAV in a 40-year-old male with human immunodeficiency virus (HIV) infection. The HAV genotype in this case was IA, which has recently become common globally among people living with HIV (PLWHIV), intravenous drug users, and homeless people especially in developed countries. His HIV infection was stabilized by antiretroviral drugs and his CD4 values were stable. He developed acute hepatic encephalopathy, did not respond to repeated plasma exchange therapy, and died rapidly. It is known that HIV co-infection sometimes leads to fulminant non-HAV hepatitis, although evidence supporting a correlation between fulminant hepatitis A risk and HIV infection is still lacking. This case demonstrated the fatal risk of HAV infection in PLWHIV; it was suggested that education about appropriate preventive measures and vaccination are important for preventing HAV infections among PLWHIV.
Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fulminant hepatitis; Hepatitis A virus (HAV); Human immunodeficiency virus (HIV); Sexually transmitted disease

Year:  2019        PMID: 31543437     DOI: 10.1016/j.jiac.2019.08.010

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  3 in total

Review 1.  Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Mitsuhiko Moriyama
Journal:  Viruses       Date:  2020-05-12       Impact factor: 5.048

Review 2.  Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Taku Mizutani; Naoki Matsumoto; Kazushige Nirei; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

3.  High prevalence of hepatitis A in indigenous population in north Brazil.

Authors:  Vanessa Salete de Paula; Flavio Augusto Pádua Milagres; Guilherme de Macêdo Oliveira; Juliana Custódio Miguel; Helena Medina Cruz; Leticia de Paula Scalioni; Vanessa Alves Marques; Monica de Avelar Figueiredo Mafra Magalhães; Anselmo Rocha Romão; Renata Gracie; Livia Melo Villar
Journal:  BMC Res Notes       Date:  2020-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.